• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

支架内新生动脉粥样硬化与慢性肾脏病关系的研究:一项光学相干断层扫描研究

Study on the relationship between in-stent neoatherosclerosis and chronic kidney disease: an optical coherence tomography study.

作者信息

Gao Yixuan, Gu Ning, Zhou Yanna, Wang Yan, Zhao Ranzun, Shi Bei

机构信息

Department of Cardiology, Affiliated Hospital of Zunyi Medical University, No. 149 of Road Dalian, District Huichuan, Zunyi, 563000, China.

Department of Epidemiology and Health Statistics, Zunyi Medical University, Zunyi, 563000, China.

出版信息

Sci Rep. 2025 Jul 1;15(1):21304. doi: 10.1038/s41598-025-05441-y.

DOI:10.1038/s41598-025-05441-y
PMID:40594527
Abstract

The relationship between in-stent neoatherosclerosis (ISNA) and chronic kidney disease (CKD) was investigated among patients exhibiting in-stent restenosis (ISR) after drug-eluting stent (DES) implantation. A total of 220 patients with confirmed in-stent restenosis (ISR) via coronary arteriography between 2020 and 2023 were enrolled. Patients were stratified into three groups based on estimated glomerular filtration rate (eGFR) levels: (1) normal renal function (eGFR ≥ 90 mL/min/1.73 m², n = 80), (2) mild renal impairment (60 ≤ eGFR < 90 mL/min/1.73 m², n = 86), and (3) kidney failure (eGFR < 60 mL/min/1.73 m², n = 54). Baseline clinical characteristics, angiographic parameters, and optical coherence tomography (OCT) data were collected and analyzed across all groups. No significant differences in angiographic characteristics were found between the three groups (p > 0.05). Patients with kidney failure demonstrated significantly higher rates of both in-stent neoatherosclerosis (ISNA) (68.5% vs. 46.5% vs. 42.5%; p < 0.05) and thin-cap fibroatheroma (TCFA) within ISR lesions (40.7% vs. 22.1% vs. 22.5%; p < 0.05) compared to those with mild or normal renal function, respectively. Lower eGFR levels were associated with a higher incidence of ISNA and reduced neointima stability.

摘要

在药物洗脱支架(DES)植入后出现支架内再狭窄(ISR)的患者中,研究了支架内新生动脉粥样硬化(ISNA)与慢性肾脏病(CKD)之间的关系。共有220例在2020年至2023年期间经冠状动脉造影确诊为支架内再狭窄(ISR)的患者入组。根据估计肾小球滤过率(eGFR)水平将患者分为三组:(1)肾功能正常(eGFR≥90 mL/min/1.73 m²,n = 80),(2)轻度肾功能损害(60≤eGFR<90 mL/min/1.73 m²,n = 86),以及(3)肾衰竭(eGFR<60 mL/min/1.73 m²,n = 54)。收集并分析了所有组的基线临床特征、血管造影参数和光学相干断层扫描(OCT)数据。三组之间在血管造影特征方面未发现显著差异(p>0.05)。与轻度肾功能或肾功能正常的患者相比,肾衰竭患者的支架内新生动脉粥样硬化(ISNA)发生率(分别为68.5%对46.5%对42.5%;p<0.05)和ISR病变内薄帽纤维粥样瘤(TCFA)发生率(分别为40.7%对22.1%对22.5%;p<0.05)均显著更高。较低的eGFR水平与ISNA的较高发生率和新生内膜稳定性降低相关。

相似文献

1
Study on the relationship between in-stent neoatherosclerosis and chronic kidney disease: an optical coherence tomography study.支架内新生动脉粥样硬化与慢性肾脏病关系的研究:一项光学相干断层扫描研究
Sci Rep. 2025 Jul 1;15(1):21304. doi: 10.1038/s41598-025-05441-y.
2
Association of the monocytes to high-density lipoprotein cholesterol ratio with in-stent neoatherosclerosis and plaque vulnerability: An optical coherence tomography study.单核细胞/高密度脂蛋白胆固醇比值与支架内新动脉粥样硬化及斑块易损性的相关性:一项光学相干断层成像研究。
Int J Cardiol. 2024 Feb 1;396:131417. doi: 10.1016/j.ijcard.2023.131417. Epub 2023 Oct 4.
3
[Optical coherence tomographic analysis of in-stent neoatherosclerosis in lesions with restenosis after drug-eluting stent implantation].[药物洗脱支架植入术后再狭窄病变中支架内新生动脉粥样硬化的光学相干断层扫描分析]
Zhonghua Xin Xue Guan Bing Za Zhi. 2018 Jan 24;46(1):44-49. doi: 10.3760/cma.j.issn.0253-3758.2018.01.008.
4
Safety and Efficacy of Cobalt Chromium Everolimus-Eluting Stents for Treatment of In-Stent Restenosis: An ILUMIEN IV Substudy.钴铬依维莫司洗脱支架治疗支架内再狭窄的安全性和有效性:ILUMIEN IV子研究
J Am Heart Assoc. 2025 Jun 3;14(11):e039482. doi: 10.1161/JAHA.124.039482. Epub 2025 May 22.
5
Lipoprotein (a) is related to In-Stent neoatherosclerosis incidence rate and plaque vulnerability: Optical Coherence Tomography Study.脂蛋白(a)与支架内新动脉粥样硬化发生率及斑块易损性相关:光学相干断层成像研究。
Int J Cardiovasc Imaging. 2023 Feb;39(2):275-284. doi: 10.1007/s10554-022-02736-3. Epub 2022 Oct 31.
6
Biolimus-coated versus paclitaxel-coated balloons for coronary in-stent restenosis (BIO ASCEND ISR): a randomised, non-inferiority trial.载比伐卢定涂层球囊与紫杉醇涂层球囊治疗冠状动脉支架内再狭窄(BIO ASCEND ISR):一项随机、非劣效性试验。
EuroIntervention. 2024 Jul 1;20(13):e806-e817. doi: 10.4244/EIJ-D-24-00295.
7
Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.早期转介策略在管理有肾脏疾病标志物的人群中的应用:对临床有效性、成本效益和经济分析证据的系统评价。
Health Technol Assess. 2010 Apr;14(21):1-184. doi: 10.3310/hta14210.
8
Association Between the Neutrophil-to-Lymphocyte Ratio and in-Stent Neoatherosclerosis and Plaque Vulnerability: An Optical Coherence Tomography Study.中性粒细胞与淋巴细胞比值与支架内新动脉粥样硬化及斑块易损性的相关性:一项光学相干断层成像研究。
J Cardiovasc Pharmacol. 2024 Nov 1;84(5):506-514. doi: 10.1097/FJC.0000000000001616.
9
Different Neoatherosclerosis Patterns in Drug-Eluting- and Bare-Metal Stent Restenosis - Optical Coherence Tomography Study.药物洗脱支架和裸金属支架再狭窄的不同新生动脉粥样硬化模式:光学相干断层成像研究
Circ J. 2019 Jan 25;83(2):313-319. doi: 10.1253/circj.CJ-18-0701. Epub 2018 Nov 29.
10
Renal Function-Stratified Comparison of Short- and Long-Term Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention With Third-Generation Drug-Eluting Stents - Post Hoc Analysis From the HOST-IDEA Randomized Clinical Trial.肾功能分层:接受第三代药物洗脱支架经皮冠状动脉介入治疗患者短期与长期双重抗血小板治疗的比较——HOST-IDEA随机临床试验的事后分析
Circ J. 2025 Feb 25;89(3):281-291. doi: 10.1253/circj.CJ-24-0481. Epub 2024 Oct 12.

本文引用的文献

1
Atherosclerosis and Epigenetic Modifications in Chronic Kidney Disease.动脉粥样硬化与慢性肾脏病中的表观遗传修饰。
Nephron. 2023;147(11):655-659. doi: 10.1159/000531292. Epub 2023 Jul 17.
2
Report on cardiovascular health and diseases in China 2021: an updated summary.《2021年中国心血管健康与疾病报告:最新概要》
J Geriatr Cardiol. 2023 Jun 28;20(6):399-430. doi: 10.26599/1671-5411.2023.06.001.
3
Pathophysiology and Clinical Impacts of Chronic Kidney Disease on Coronary Artery Calcification.慢性肾脏病对冠状动脉钙化的病理生理学及临床影响
J Cardiovasc Dev Dis. 2023 May 10;10(5):207. doi: 10.3390/jcdd10050207.
4
Impact of triglyceride-rich lipoproteins on early in-stent neoatherosclerosis formation in patients undergoing statin treatment.富含甘油三酯的脂蛋白对接受他汀类药物治疗患者早期支架内新生动脉粥样硬化形成的影响。
J Clin Lipidol. 2023 Mar-Apr;17(2):281-290. doi: 10.1016/j.jacl.2023.01.004. Epub 2023 Jan 26.
5
Neoatherosclerosis prediction using plaque markers in intravascular optical coherence tomography images.利用血管内光学相干断层扫描图像中的斑块标志物预测新动脉粥样硬化
Front Cardiovasc Med. 2022 Dec 14;9:1079046. doi: 10.3389/fcvm.2022.1079046. eCollection 2022.
6
Prevalence, Morphology, and Predictors of Intra-Stent Plaque Rupture in Patients with Acute Coronary Syndrome: An Optical Coherence Tomography Study.急性冠状动脉综合征患者支架内斑块破裂的患病率、形态学及预测因素:光学相干断层成像研究。
Clin Appl Thromb Hemost. 2022 Jan-Dec;28:10760296221146742. doi: 10.1177/10760296221146742.
7
Lipoprotein (a) is related to In-Stent neoatherosclerosis incidence rate and plaque vulnerability: Optical Coherence Tomography Study.脂蛋白(a)与支架内新动脉粥样硬化发生率及斑块易损性相关:光学相干断层成像研究。
Int J Cardiovasc Imaging. 2023 Feb;39(2):275-284. doi: 10.1007/s10554-022-02736-3. Epub 2022 Oct 31.
8
Coronary artery calcification in patients with advanced chronic kidney disease.晚期慢性肾脏病患者的冠状动脉钙化。
BMC Cardiovasc Disord. 2022 Oct 29;22(1):453. doi: 10.1186/s12872-022-02879-0.
9
Prevalence and Impact of Neoatherosclerosis on Clinical Outcomes After Percutaneous Treatment of Second-Generation Drug-Eluting Stent Restenosis.第二代药物洗脱支架再狭窄经皮治疗后新生动脉粥样硬化的流行及对临床结局的影响。
Circ Cardiovasc Interv. 2022 Sep;15(9):e011693. doi: 10.1161/CIRCINTERVENTIONS.121.011693. Epub 2022 Sep 20.
10
Intravascular imaging in coronary stent restenosis: Prevention, characterization, and management.冠状动脉支架再狭窄的血管内成像:预防、特征分析与管理。
Front Cardiovasc Med. 2022 Aug 9;9:843734. doi: 10.3389/fcvm.2022.843734. eCollection 2022.